Tandem Diabetes (TNDM) announced the launch of updated t:slim X2 insulin pump software with Dexcom (DXCM) G7 Continuous Glucose Monitoring, or CGM, integration in the United States. Tandem’s automated insulin delivery system with Control-IQ technology is the only AID option in the world to use Dexcom’s latest CGM technology. Tandem will email instructions to all in-warranty t:slim X2 users in the United States to offer the option to add the new feature free of charge via remote software update. t:slim X2 pumps pre-loaded with the updated software are now shipping to new customers.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on TNDM:
- Tandem Diabetes price target lowered to $39 from $62 at Barclays
- Tandem Diabetes price target lowered to $35 from $50 at Craig-Hallum
- Tandem Diabetes price target lowered to $22 from $34 at TD Cowen
- Tandem Diabetes price target lowered to $25 from $40 at Piper Sandler
- Tandem Diabetes price target lowered to $20 from $32 at Baird